Cizzle Biotechnology Holdings Plc

1.15pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:CIZHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 5Y CAGR (28.25%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.12)
PE TTM —
TSR TTM (20.69%)
Mkt cap £4.887M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
1.43p
24.70%
(14.61%)
Hold 6|12|10|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.01
0.01
0.01
0.02
10.10%
8.15%
26.16%
32.64%
Revenue£M
0.396
0.417
0.407
0.426
9.50%
10.29%
2.23%
5.52%
Peers (US$6.690M)
Cap (US$)
PE
6.316M
—
6.746M
—
Capital
TTM
5Y
10Y
Leveragex
0.194
0.332
0.309
EBIT/Intx
0.362
0.658
0.506
Own earn%
(45.48)
(8.87)
(13.14)
Sh yield%
26.77
32.25
32.13
Owners
Insiders/Inst%
12.12
28.69
Short interest%
2.25
SBC / revenue%
4.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
24–31
$1 testx
—
Incr. ROIC%
8